Home

What's New

Media Hit | Health Care

Consumers are paying more money for certain drugs

The California Public Interest Research Group  released the report on  a practice critics call "Pay for delay."   That's when brand name drug companies pay off generic manufacturers to delay putting generic versions on the market.  As a result, consumers end up paying a lot more. The study found in some cases hundreds of dollars more were spent on meds used to treat cancer,  depression and heart disease. 

> Keep Reading
Media Hit | Health Care

Pharmaceutical companies pay to delay generics

The report, from the California Public Interest Research Group and Community Catalyst, a nonprofit advocate for affordable health care, said pay-for-delay deals enable companies to continue to sell their brand-name drugs at high prices well after their original patents have expired.

> Keep Reading
Media Hit | Health Care

Drug Makers Stall Generics With “Pay For Delay” Says CALPIRG

The California Public Interest Research Group or CALPIRG has released details on what it says is a practice that leads to prescription drug price inflation. CALPIRG calls it “pay for delay.” CALPIRG says the practice of keeping generics off the market makes consumers pay more for medications that treat conditions like cancer and high cholesterol.

> Keep Reading
Media Hit | Health Care

CALPIRG study claims drug companies hold back generic meds

SACRAMENTO, Calif. (KCRA) —A study by a public interest group found Californians have overpaid for medications because brand-made drugs were delayed from reaching pharmacies.

Read more: http://www.kcra.com/news/calpirg-study-claims-drug-companies-hold-back-generic-meds/-/11797728/20945964/-/uh9rdr/-/index.html#ixzz2YrSJnikK

> Keep Reading
News Release | CALPIRG | Health Care

Twenty Top Generic Drugs Delayed By Industry Payoffs

The report, “Top Twenty Pay-for-Delay Drugs: How Drug Industry Payoffs Delay Generics, Inflate Prices and Hurt Consumers” reveals that these drugs were subject to an industry practice called “pay for delay,” in which brand name pharmaceutical companies pay off generic drug manufacturers to keep lower cost equivalents off the market, forcing consumers to pay higher brand-name drug prices.

> Keep Reading

Pages

Media Hit | Democracy

The Sacramento Bee: Bill seeks to curb corporate political spending

Democratic lawmakers took aim Monday at corporate political spending after businesses poured millions of dollars into measures on the California primary ballot.

> Keep Reading
Media Hit | Democracy

The San Francisco Chronicle: Politicians raise money outside their districts

California's state legislators collect the vast majority of their campaign contributions from organizations and individuals outside the districts they represent, according to a study by the nonprofit organization Maplight.org.

> Keep Reading
Media Hit | Transportation

Los Angeles Times: L.A. mass transit agencies make only a token effort to get people onboard

Your basic middle-class L.A. household spends about $8,600 a year on gas, insurance, parking and vehicle maintenance, according to the California Public Interest Research Group, a watchdog organization.

> Keep Reading

The Sacramento Bee: Finding out who sells personal info to junk-mail firms is tough

Californians often are frustrated in attempts to determine which businesses are selling their personal information to junk-mail firms, according to a study released Wednesday by the California Public Interest Research Group.

> Keep Reading

Pages

DEFEND THE CFPB

Tell your senators to oppose the “Financial CHOICE Act,” which would gut Wall Street reforms and destroy the Consumer Financial Protection Bureau as we know it.

Support Us

Your donation supports CALPIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.
Optional Member Code